UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 880

Sortiert nach

Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma

Annals of oncology, 2012-03, Vol.23 (3), p.736-742

2012

Volltextzugriff (PDF)

High incidence of false-positive PET scans in patients with aggressive non-Hodgkin's lymphoma treated with rituximab-containing regimens

Annals of oncology, 2009-02, Vol.20 (2), p.309-318

2009

Volltextzugriff (PDF)

Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies

Leukemia, 2003-04, Vol.17 (4), p.789-795

2003

Volltextzugriff (PDF)

Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation

Leukemia, 2012-04, Vol.26 (4), p.814-821

2012

Volltextzugriff (PDF)

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Nature (London), 2000-02, Vol.403 (6769), p.503-511

2000

Volltextzugriff (PDF)

AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity

Leukemia, 2004-11, Vol.18 (11), p.1775-1779

2004

Volltextzugriff (PDF)

The Inference of Antigen Selection on Ig Genes

The Journal of immunology (1950), 2000-11, Vol.165 (9), p.5122-5126

2000

Volltextzugriff (PDF)

Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas

Blood, 2000-03, Vol.95 (5), p.1797-1803

2000

Volltextzugriff (PDF)

Higher-grade transformation of follicular lymphoma - a continuous enigma

Leukemia, 2005-08, Vol.19 (8), p.1331-1333

Lossos, I S

2005

Volltextzugriff (PDF)

Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs

Leukemia, 2015-11, Vol.29 (11), p.2270-2273

2015

Volltextzugriff (PDF)

Apoptosis-stimulating protein of p53-2 (ASPP2 ) is an E2F target gene

Cell death and differentiation, 2005-04, Vol.12 (4), p.358-368

2005

Volltextzugriff (PDF)

Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5' noncoding regulatory region of the BCL-6 gene

Blood, 2000-07, Vol.96 (2), p.635-639

2000

Volltextzugriff (PDF)

Prediction of Survival in Diffuse Large-B-Cell Lymphoma Based on the Expression of Six Genes

The New England journal of medicine, 2004-04, Vol.350 (18), p.1828-1837

2004

Volltextzugriff (PDF)

BCL-6 mRNA expression in higher grade transformation of follicle center lymphoma: correlation with somatic mutations in the 5' regulatory region of the BCL-6 gene

Leukemia, 2002-09, Vol.16 (9), p.1857-1862

2002

Volltextzugriff (PDF)

Spontaneous pneumomediastinum. A report of 25 cases

Chest, 1991-07, Vol.100 (1), p.93-95

1991

Volltextzugriff (PDF)

Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype

Oncogene, 2017-07, Vol.36 (29), p.4224-4232

2017

Volltextzugriff (PDF)

Outcomes in primary gastrointestinal (GI) follicular lymphoma (FL): results from a multicenter analysis

Hematological oncology, 2023-06, Vol.41 (S2), p.380-381

2023

Volltextzugriff (PDF)

Chlamydophila psittaci-negative ocular adnexal marginal zone lymphomas express self polyreactive B-cell receptors

Leukemia, 2015-07, Vol.29 (7), p.1587-1599

2015

Volltextzugriff (PDF)

Mutation analysis of the 5′ noncoding regulatory region of the BCL-6 gene in non-Hodgkin lymphoma: evidence for recurrent mutations and intraclonal heterogeneity

Blood, 2000-02, Vol.95 (4), p.1400-1405

2000

Volltextzugriff (PDF)

PROMISING CLINICAL DATA FROM DOSE ESCALATION IN A PHASE IB/II ONGOING STUDY OF MOSUNETUZUMAB WITH POLATUZUMAB VEDOTIN FOR RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN’S LYMPHOMA

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

P1129: ACALABRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): RESULTS OF A PHASE 2, MULTICENTER, OPEN‐LABEL TRIAL

HemaSphere, 2022-06, Vol.6 (Suppl), p.1019-1020

2022

Volltextzugriff (PDF)

P1114: ZANDELISIB ON INTERMITTENT DOSING AS A SINGLE AGENT OR IN COMBINATION WITH RITUXIMAB OR ZANUBRUTINIB IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): RESULTS FROM A MULTI‐ARM PHASE 1B STUDY

HemaSphere, 2022-06, Vol.6 (Suppl), p.1004-1005

2022

Volltextzugriff (PDF)

Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma

Blood, 2001-08, Vol.98 (4), p.945-951

2001

Volltextzugriff (PDF)

The BCL6 gene in B-cell lymphomas with 3q27 translocations is expressed mainly from the rearranged allele irrespective of the partner gene

Leukemia, 2003-07, Vol.17 (7), p.1390-1397

2003

Volltextzugriff (PDF)

Transformation of Follicular Lymphoma to Diffuse Large-Cell Lymphoma: Alternative Patterns with Increased or Decreased Expression of c-myc and Its Regulated Genes

Proceedings of the National Academy of Sciences - PNAS, 2002-06, Vol.99 (13), p.8886-8891

2002

Volltextzugriff (PDF)

1 – 25 von 880

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(807)
Mit Volltextzugriff
(777)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(501)
Life Sciences & Biomedicine
(484)
Humans
(467)
Male
(259)
Female
(252)
Adult
(223)
Middle Aged
(192)
Biological And Medical Sciences
(190)
Medical Sciences
(187)
Hematology
(181)
Aged
(129)
Oncology
(120)
Lymphoma
(95)
Infectious Diseases
(76)
Hematologic And Hematopoietic Diseases
(73)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(70)
Treatment Outcome
(67)
Neurosciences & Neurology
(63)
Adolescent
(61)
Clinical Neurology
(59)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(183)
Leukemia & Lymphoma
(54)
Journal Of Clinical Oncology
(32)
Neuro-Oncology
(25)
British Journal Of Haematology
(22)
American Journal Of Hematology
(21)
Blood Advances
(17)
Aids
(14)
Hiv Medicine
(13)
American Journal Of Clinical Pathology
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma

High incidence of false-positive PET scans in patients with aggressive non-Hodgkin's lymphoma treated with rituximab-containing regimens

Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies

Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity

The Inference of Antigen Selection on Ig Genes

Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas

Higher-grade transformation of follicular lymphoma - a continuous enigma

Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs

Apoptosis-stimulating protein of p53-2 (ASPP2 ) is an E2F target gene

Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5' noncoding regulatory region of the BCL-6 gene

Prediction of Survival in Diffuse Large-B-Cell Lymphoma Based on the Expression of Six Genes

BCL-6 mRNA expression in higher grade transformation of follicle center lymphoma: correlation with somatic mutations in the 5' regulatory region of the BCL-6 gene

Spontaneous pneumomediastinum. A report of 25 cases

Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype

Outcomes in primary gastrointestinal (GI) follicular lymphoma (FL): results from a multicenter analysis

Chlamydophila psittaci-negative ocular adnexal marginal zone lymphomas express self polyreactive B-cell receptors

Mutation analysis of the 5′ noncoding regulatory region of the BCL-6 gene in non-Hodgkin lymphoma: evidence for recurrent mutations and intraclonal heterogeneity

PROMISING CLINICAL DATA FROM DOSE ESCALATION IN A PHASE IB/II ONGOING STUDY OF MOSUNETUZUMAB WITH POLATUZUMAB VEDOTIN FOR RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN’S LYMPHOMA

P1129: ACALABRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): RESULTS OF A PHASE 2, MULTICENTER, OPEN‐LABEL TRIAL

P1114: ZANDELISIB ON INTERMITTENT DOSING AS A SINGLE AGENT OR IN COMBINATION WITH RITUXIMAB OR ZANUBRUTINIB IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): RESULTS FROM A MULTI‐ARM PHASE 1B STUDY

Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma

The BCL6 gene in B-cell lymphomas with 3q27 translocations is expressed mainly from the rearranged allele irrespective of the partner gene

Transformation of Follicular Lymphoma to Diffuse Large-Cell Lymphoma: Alternative Patterns with Increased or Decreased Expression of c-myc and Its Regulated Genes

Suchergebnisse filtern